Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?
Yahoo Finance
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
FBT delivered 52. 4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier performance.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance